STAG2 as a biomarker for prediction of recurrence in papillary non-muscle invasive bladder cancer

被引：0
|
作者：
Lelo, Alana [1 ]
Harris, Brent T. [1 ]
Berry, Deborah L. [1 ]
Chaldekas, Krysta [1 ]
Kumar, Anagha [2 ]
Solomon, David [3 ]
Simko, Jeffry [3 ]
Bhattacharyya, Pritish [4 ]
Mannion, Ciaran [4 ]
Kim, Jung-Sik [1 ]
Philips, George [5 ]
Waldman, Todd [1 ]
机构：
[1] Georgetown Univ, Washington, DC USA
[2] Medstar Hlth Res Inst, Washington, DC USA
[3] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[4] Hackensack Univ Med Ctr, Hackensack, NJ USA
[5] Medstar Washington Hosp Ctr, Washington, DC USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1558
引用
收藏
页数：2
相关论文
共 50 条
  • [1] STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer
    Lelo, Alana
    Prip, Frederik
    Harris, Brent T.
    Solomon, David
    Berry, Deborah L.
    Chaldekas, Krysta
    Kumar, Anagha
    Simko, Jeffry
    Jensen, Jorgen Bjerggaard
    Bhattacharyya, Pritish
    Mannion, Ciaran
    Kim, Jung-Sik
    Philips, George
    Dyrskjot, Lars
    Waldman, Todd
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4145 - 4153
  • [2] Re: STAG2 is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2020, 204 (04): : 877 - 877
  • [3] STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer
    Taber, Ann
    Park, Youngrok
    Lelo, Alana
    Prip, Frederik
    Xiao, Jerry
    Berry, Deborah L.
    Chaldekas, Krysta
    Jensen, Jorgen Bjerggaard
    Philips, George
    Kim, Jung-Sik
    Harris, Brent T.
    Dyrskjot, Lars
    Waldman, Todd
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (07) : 438.e1 - 438.e9
  • [4] Relationship of STAG2 Expression with Intrinsic Molecular Subtypes and Recurrence/Progression Status in Non-Muscle-Invasive Bladder Cancer
    Erdem, Zeynep Betul
    Cakir, Caglar
    Otunctemur, Alper
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 554 - 555
  • [5] Relationship of STAG2 Expression with Intrinsic Molecular Subtypes and Recurrence/Progression Status in Non-Muscle-Invasive Bladder Cancer
    Erdem, Zeynep Betul
    Cakir, Caglar
    Otunctemur, Alper
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 554 - 555
  • [6] PROTEIN DISULFIDE ISOMERASE AS A PREDICTIVE BIOMARKER FOR NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE
    Yuen, Kit L.
    Wu, Chia-Hao
    Silvers, Christopher R.
    Steinmetz, Alexis
    Miyamoto, Hiroshi
    Messing, Edward M.
    Lee, Yi-Fen
    JOURNAL OF UROLOGY, 2022, 207 (05): : E934 - E935
  • [7] Prediction for recurrent non-muscle invasive bladder cancer
    Li, Keqiang
    Raveendran, Aravind
    Xie, Guoqing
    Zhang, Yu
    Wu, Haofan
    Huang, Zhenlin
    Jia, Zhankui
    Yang, Jinjian
    CANCER BIOMARKERS, 2023, 38 (03) : 275 - 285
  • [8] Prediction tools in non-muscle invasive bladder cancer
    Zamboni, Stefania
    Moschini, Marco
    Simeone, Claudio
    Antonelli, Alessandro
    Mattei, Agostino
    Baumeister, Philipp
    Xylinas, Evanguelos
    Hakenberg, Oliver W.
    Aziz, Atiqullah
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 39 - 45
  • [9] Identifying targeted therapies for muscle invasive bladder cancer via STAG2 expression
    Athans, Sarah R.
    Withers, Henry
    Kazmierczak, Zara
    Gurova, Katerina
    Woloszynska, Anna
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [10] Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
    Tan, Wei Shen
    Tan, Wei Phin
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S109 - S110
12345